Hi @Titans19 good morning
Mason's reference article (4) in his post above is about individual dosing / precision dosing.
That made me think that companies where dosing is controversial should maybe consider individualised precision dosing rather than the same fixed amount for all patients.
e.g. that may apply to CNS drugs.
- Forums
- ASX - By Stock
- RAC
- Speculative M&A Transaction Analysis
Speculative M&A Transaction Analysis, page-190
-
-
- There are more pages in this discussion • 665 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
0.010(0.63%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.56 | $168.3K | 106.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51 | $1.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 54981 | 1.550 |
1 | 700 | 1.520 |
1 | 2750 | 1.510 |
3 | 7984 | 1.505 |
5 | 17550 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 20000 | 1 |
1.620 | 2000 | 1 |
1.685 | 5000 | 1 |
1.690 | 6570 | 3 |
1.695 | 7731 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |